Decision concerning the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings scheduled for January 16, 2024
December 18 2023 - 1:00PM
Decision concerning the adoption of a
sale plan (plan de cession) and
the opening of judicial liquidation proceedings scheduled for
January 16, 2024
Paris, France, December 18,
2023 – 7:00 pm
(CET) – Pixium Vision SA (Euronext Growth Paris -
FR001400JX97; Mnemo: ALPIX), a bioelectronics company developing
innovative vision systems to enable patients who have lost their
sight to live more independent lives, announces that following
today's hearing, the Paris Commercial Court will issue its decision
on January 16, 2024 on the takeover offer filed on November 20,
2023 and the opening of judicial liquidation proceedings.
In the event of the opening of judicial
liquidation proceedings, Euronext will delist Pixium’s shares.
Pixium draws investors’ attention to the fact
that, given the current offer and the Company's level of
indebtedness, the sale proceeds received in the event of a
favourable decision by the Commercial Court will not allow a total
or partial reimbursement of shareholders.
About Pixium Vision
Pixium Vision is creating a
world of bionic vision for those who have lost their sight,
enabling them to regain visual perception and greater autonomy.
Pixium Vision’s bionic vision systems are associated with a
surgical intervention and a rehabilitation period. Prima System
sub-retinal miniature photovoltaic wireless implant is in clinical
testing for patients who have lost their sight due to outer retinal
degeneration, initially for atrophic dry age-related macular
degeneration (dry AMD). Pixium Vision collaborates closely with
academic and research partners, including some of the most
prestigious vision research institutions in the world, such as
Stanford University in California, Institut de la Vision in Paris,
Moorfields Eye Hospital in London, Institute of Ocular Microsurgery
(IMO) in Barcelona, University hospital in Bonn, and UPMC in
Pittsburgh, PA. The Company is EN ISO 13485 certified and qualifies
as “Entreprise Innovante” by Bpifrance.
For more information:
http://www.pixium-vision.com/fr
Follow us on @PixiumVision;
www.facebook.com/pixiumvision
www.linkedin.com/company/pixium-vision
Contacts
Investor
RelationsPixium VisionOffer NonhoffChief
Financial Officerinvestors@pixium-vision.com |
Media
Relations Rose Piquante ConsultingSophie
BaumontSophie.baumont@rosepiquante-consulting.com+33 6 27 74 74
49 |
- Pixium - PR decision date of the court - 18.12.2023
Pixium Vision (EU:ALPIX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Pixium Vision (EU:ALPIX)
Historical Stock Chart
From Jul 2023 to Jul 2024